
(Dollars and shares in thousands except per share amounts) | Three months ended March 31, | ||
2026 | 2025 | ||
Revenues ................................................................................................................... | $61 | $— | |
Costs and expenses: | |||
Operation and maintenance .................................................................................... | 482 | 252 | |
Research and development income, net .................................................................. | (72) | (36) | |
General and administrative expense ........................................................................ | 16,990 | 7,679 | |
Operating lease expense .......................................................................................... | 2,620 | 1,989 | |
Depreciation and amortization ................................................................................ | 93 | 47 | |
Operating loss ...................................................................................................... | (20,052) | (9,931) | |
Other income (expense): | |||
Interest income ....................................................................................................... | 2,815 | 2,028 | |
Interest expense ...................................................................................................... | (2,717) | (1,227) | |
Other non-operating expense, net ............................................................................ | (11,876) | (16) | |
Loss before income taxes .......................................................................................... | (31,830) | (9,146) | |
Net loss ..................................................................................................................... | $(31,830) | $(9,146) | |
Net loss per share information: | |||
Net loss ................................................................................................................... | $(31,830) | $(9,146) | |
Less: Remeasurement of redeemable noncontrolling interest ................................. | (3,434) | — | |
Net loss attributable to common shares, basic and diluted .................................... | (35,264) | (9,146) | |
Weighted average shares, basic and diluted (1) ................................................... | 9,467 | 8,961 | |
Net loss per share attributable to common stockholders, basic and diluted (1) ... | $(3.72) | $(1.02) | |
(Dollars and shares in thousands) | As of March 31, | As of December 31, | |
2026 | 2025 | ||
ASSETS | |||
Current assets: | |||
Cash and cash equivalents ..................................................................................... | $280,776 | $461,836 | |
Grant receivables ................................................................................................... | 16,755 | 10,580 | |
Prepaid expenses and other ................................................................................... | 10,338 | 9,714 | |
Total current assets .......................................................................................... | 307,869 | 482,130 | |
Deposits ................................................................................................................. | 15,242 | 15,234 | |
Construction-in-process ........................................................................................ | 972,040 | 789,571 | |
Operating leases right of use assets ....................................................................... | 91,112 | 58,713 | |
Restricted cash ...................................................................................................... | 6,000 | 6,000 | |
Other long-term assets ........................................................................................... | 35,244 | 13,520 | |
Total assets ....................................................................................................... | $1,427,507 | $1,365,168 | |
LIABILITIES AND EQUITY | |||
Current liabilities: | |||
Accounts payable ................................................................................................... | $8,043 | $10,789 | |
Accrued capital expenditures .................................................................................... | 147,610 | 119,303 | |
Operating lease liabilities ........................................................................................ | 25,335 | 4,822 | |
Other current liabilities ............................................................................................ | 20,932 | 16,997 | |
Total current liabilities ....................................................................................... | 201,920 | 151,911 | |
Long-term debt, net of issuance costs ...................................................................... | 186,636 | 172,837 | |
Operating lease liabilities ........................................................................................ | 86,349 | 72,639 | |
Other long-term liabilities ....................................................................................... | 24,673 | 11,407 | |
Total liabilities ................................................................................................. | 499,578 | 408,794 | |
Commitments and Contingencies (Note 16) ............................................................ | |||
Redeemable convertible preferred stock | |||
Redeemable convertible preferred stock, par value $0.0001 per share; 283,546 and 283,546 authorized; 279,995 and 279,995 issued and outstanding as of March 31, 2026 and December 31, 2025, respectively ......................................... | 1,022,886 | 1,022,942 | |
Redeemable noncontrolling interest | |||
Cape Phase I HoldCo - Redeemable noncontrolling interest | 103,843 | 102,586 | |
Cape Phase I Intermediate HoldCo - Redeemable noncontrolling interest | 79,521 | 77,344 | |
Stockholders’ deficit: | |||
Common stock, par value $0.0001 per share; 358,279 and 358,279 authorized; 9,873 and 9,457 issued as of March 31, 2026 and December 31, 2025, respectively(1) | 1 | 1 | |
Additional paid-in capital | — | — | |
Treasury stock, at cost; 270 and 270 shares as of March 31, 2026 and December 31, 2025, respectively (1) .................................................................. | (1,960) | (1,960) | |
Accumulated deficit .............................................................................................. | (276,362) | (244,539) | |
Total stockholders’ deficit .................................................................................. | (278,321) | (246,498) | |
Total liabilities, redeemable convertible preferred stock, redeemable noncontrolling interests and stockholders’ deficit .............................................. | $1,427,507 | $1,365,168 |